Junlan Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Junlan Qiu has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Xiaochen Shu
Department of Epidemiology, School of Public Health, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China
7 shared publications - Qinqin Gao
Institute for Fetology, the First Affiliated Hospital of Soochow University, Suzhou, China
5 shared publications Bingyu Ji
Institute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
3 shared publicationsFang Meng
National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College
3 shared publicationsFengying Deng
Institute for Fetology, the First Affiliated Hospital of Soochow University, Suzhou, China
3 shared publicationsJiahui Lei
Institute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Springer Nature in Journal of Nanobiotechnology
Spatiotemporally programmed probiotic vaccines potentiate the efficacy of single-epitope neoantigen immunotherapy for solid tumors
- 16 October 2026
- Published by Springer Nature in Journal of Nanobiotechnology
Open AccessSpatiotemporally programmed probiotic vaccines potentiate the efficacy of single-epitope neoantigen immunotherapy for solid tumors
- 15 October 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (11) , 461
Structure-based development of Glypican-3-targeting peptide candidates for hepatocellular carcinoma
Hepatocellular carcinoma remains highly lethal, and extracellular GPC3 provides a tumor-associated surface target for structure-guided peptide design. This study established an entirely in silico workflow for de novo discovery and prioritization of GPC3-targeting peptide candidates using the human GPC3 structure from Protein Data Bank entry 7ZAW. W260, Y264, and M269 were selected as coordinate-resolved hotspot residues. A single 100 ns apo-GPC3 simulation was performed, and the centroid of the most populated cluster, accounting for 35.6% of the stable trajectory, was used for downstream design. RFdiffusion generated 100 peptide backbones near the hotspot surface, and ProteinMPNN generated a nonredundant peptide sequence library from the retained backbones. PepPAP was used as a sequence-level prediction model to rank candidates by its model output, which was treated as a relative computational prediction value rather than an experimentally measured binding free energy. The top 120 PepPAP-ranked sequences were refined with Rosetta FlexPepDock, generating 600 receptor-peptide poses, of which 565 satisfied the applied geometry/contact criteria. The top 30 docked peptides were evaluated using in silico solubility and toxicity predictors; 21 passed both filters. Integrated ranking identified five final priority candidates with Rosetta interface energies from − 20.459 to -18.255 REU. These peptides are computationally prioritized candidates for future experimental validation.
- 15 October 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (11) , 461
Structure-based development of Glypican-3-targeting peptide candidates for hepatocellular carcinoma
Hepatocellular carcinoma remains highly lethal, and extracellular GPC3 provides a tumor-associated surface target for structure-guided peptide design. This study established an entirely in silico workflow for de novo discovery and prioritization of GPC3-targeting peptide candidates using the human GPC3 structure from Protein Data Bank entry 7ZAW. W260, Y264, and M269 were selected as coordinate-resolved hotspot residues. A single 100 ns apo-GPC3 simulation was performed, and the centroid of the most populated cluster, accounting for 35.6% of the stable trajectory, was used for downstream design. RFdiffusion generated 100 peptide backbones near the hotspot surface, and ProteinMPNN generated a nonredundant peptide sequence library from the retained backbones. PepPAP was used as a sequence-level prediction model to rank candidates by its model output, which was treated as a relative computational prediction value rather than an experimentally measured binding free energy. The top 120 PepPAP-ranked sequences were refined with Rosetta FlexPepDock, generating 600 receptor-peptide poses, of which 565 satisfied the applied geometry/contact criteria. The top 30 docked peptides were evaluated using in silico solubility and toxicity predictors; 21 passed both filters. Integrated ranking identified five final priority candidates with Rosetta interface energies from − 20.459 to -18.255 REU. These peptides are computationally prioritized candidates for future experimental validation.
- Open Access
- 21 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (34) , e49842
Association of dietary inflammatory index and specific nutrients with anti-seizure medications use among U.S. adults
Anti-seizure medications (ASMs) are prescribed for epilepsy and other conditions including neuropathic pain and migraine. Dietary patterns may modulate inflammation, which has been implicated in neurological conditions. This study aimed to investigate the association of dietary inflammation, measured by the dietary inflammatory index (DII), and specific nutrients and ASM use among U.S. adults. Data were obtained from the National Health and Nutrition Examination Survey from 2013 to 2020 with 11,536 participants (46.44% female). A modified DII was calculated using 26 dietary parameters from a single 24-hour recall. ASM use was identified based on self-reported use within the past 30 days. Logistic regression models adjusted for sociodemographic and lifestyle factors were used to assess associations. Participants in the highest DII tertile (T3) had significantly higher ASM use compared to the intermediate tertile (T2) (OR = 1.63; 95% confidence interval: 1.15–2.34; P < .01). Restricted cubic spline analysis revealed a nonlinear, J-shaped relationship. The association was more prominent among females, unemployed and those with lower education, and with insufficient physical activity. Higher intake of fiber, vitamin A, and selenium was inversely associated with ASM use; however, positive associations for vitamins D, C, and B12 likely reflect supplementation practices. A pro-inflammatory diet was observed to be associated with higher ASM use, particularly in females and socioeconomically disadvantaged groups. Due to the cross-sectional design and possible potential reverse causality, these findings require confirmation in prospective studies.
- 21 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (34) , e49842
Open AccessAssociation of dietary inflammatory index and specific nutrients with anti-seizure medications use among U.S. adults
Anti-seizure medications (ASMs) are prescribed for epilepsy and other conditions including neuropathic pain and migraine. Dietary patterns may modulate inflammation, which has been implicated in neurological conditions. This study aimed to investigate the association of dietary inflammation, measured by the dietary inflammatory index (DII), and specific nutrients and ASM use among U.S. adults. Data were obtained from the National Health and Nutrition Examination Survey from 2013 to 2020 with 11,536 participants (46.44% female). A modified DII was calculated using 26 dietary parameters from a single 24-hour recall. ASM use was identified based on self-reported use within the past 30 days. Logistic regression models adjusted for sociodemographic and lifestyle factors were used to assess associations. Participants in the highest DII tertile (T3) had significantly higher ASM use compared to the intermediate tertile (T2) (OR = 1.63; 95% confidence interval: 1.15–2.34; P < .01). Restricted cubic spline analysis revealed a nonlinear, J-shaped relationship. The association was more prominent among females, unemployed and those with lower education, and with insufficient physical activity. Higher intake of fiber, vitamin A, and selenium was inversely associated with ASM use; however, positive associations for vitamins D, C, and B12 likely reflect supplementation practices. A pro-inflammatory diet was observed to be associated with higher ASM use, particularly in females and socioeconomically disadvantaged groups. Due to the cross-sectional design and possible potential reverse causality, these findings require confirmation in prospective studies.
- 25 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (9) , 2440-2449
Cumulative environmental burden and neurodegenerative disease mortality: a national ecological study in the United States
Neurodegenerative diseases (NDDs) represent a growing cause of mortality and disability among aging populations worldwide. However, the relationship between cumulative, multidomain environmental exposures, and NDD mortality remains poorly characterized. This study aimed to examine the association between comprehensive environmental quality and NDD mortality in the United States. We used the environmental quality index (EQI) from 2000 to 2005 to characterize cumulative environmental exposure. Associations between EQI quintiles and NDD mortality, including dementia, Parkinson’s disease (PD), amyotrophic lateral sclerosis, and Huntington’s disease, were examined using Bayesian interval-censored mixed-effects models. During 2006-2020, among 3.66 million NDD deaths, poorer environmental quality (Q5 vs Q1) was associated with mortality rate differences of 24.72 (95% credible intervals [CrI]: 22.43, 27.06) per 100 000 at 5-year lag, 26.74 (95% CrI: 24.34, 29.21) at 10-year lag, and 22.74 (95% CrI: 20.49, 25.13) at 15-year lag. Within each lag period, a clear dose–response pattern was consistently observed across EQI quintiles. Furthermore, associations were most pronounced for the air quality, followed by sociodemographic disadvantage. In addition, demographic and geographic heterogeneity was observed across sex, race, census regions, urbanicity, climate zone, and county economic type. These findings underscore the need for integrated, place-based environmental health policies targeting neurodegeneration prevention.
- 25 May 2026
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 195 (9) , 2440-2449
Cumulative environmental burden and neurodegenerative disease mortality: a national ecological study in the United States
Neurodegenerative diseases (NDDs) represent a growing cause of mortality and disability among aging populations worldwide. However, the relationship between cumulative, multidomain environmental exposures, and NDD mortality remains poorly characterized. This study aimed to examine the association between comprehensive environmental quality and NDD mortality in the United States. We used the environmental quality index (EQI) from 2000 to 2005 to characterize cumulative environmental exposure. Associations between EQI quintiles and NDD mortality, including dementia, Parkinson’s disease (PD), amyotrophic lateral sclerosis, and Huntington’s disease, were examined using Bayesian interval-censored mixed-effects models. During 2006-2020, among 3.66 million NDD deaths, poorer environmental quality (Q5 vs Q1) was associated with mortality rate differences of 24.72 (95% credible intervals [CrI]: 22.43, 27.06) per 100 000 at 5-year lag, 26.74 (95% CrI: 24.34, 29.21) at 10-year lag, and 22.74 (95% CrI: 20.49, 25.13) at 15-year lag. Within each lag period, a clear dose–response pattern was consistently observed across EQI quintiles. Furthermore, associations were most pronounced for the air quality, followed by sociodemographic disadvantage. In addition, demographic and geographic heterogeneity was observed across sex, race, census regions, urbanicity, climate zone, and county economic type. These findings underscore the need for integrated, place-based environmental health policies targeting neurodegeneration prevention.
- Open Access
- 28 December 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Causal relationship between diet and common female diseases: a comprehensive Mendelian randomization study
This study aimed to investigate the causal relationship between dietary habits and nine common diseases with high female prevalence using a two-sample Mend
- 28 December 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open AccessCausal relationship between diet and common female diseases: a comprehensive Mendelian randomization study
This study aimed to investigate the causal relationship between dietary habits and nine common diseases with high female prevalence using a two-sample Mend
- 15 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 167, 115680
High expression of SENP1 correlates with poor prognosis and immune evasion in gastric cancer
- 15 October 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 167, 115680
High expression of SENP1 correlates with poor prognosis and immune evasion in gastric cancer
- Open Access
- 13 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2494
Thymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Background/Objectives: T cell dysfunction represents a fundamental barrier to effective cancer immunotherapy. Although immune checkpoint blockades and adoptive cell transfer have achieved clinical success, therapeutic resistance remains prevalent across cancer types. Thymopentin (TP5), a synthetic immunomodulatory pentapeptide (Arg-Lys-Asp-Val-Tyr), has demonstrated immunostimulatory properties, yet its anticancer potential remains unexplored. The aim of this study was to investigate TP5’s antitumor efficacy and underlying immunological mechanisms. Methods: We evaluated TP5’s therapeutic effects in multiple murine tumor models, including B16-F10 melanoma, MC38 colorectal carcinoma, Hepa 1-6, and LM3 hepatocellular carcinoma. Immune cell populations and functional states were characterized using flow cytometry, ELISAs, and immunofluorescence analyses. The potential of TP5 as an adjuvant for T cell-based therapies was also systematically assessed. Results: The TP5 treatment markedly suppressed tumor growth across caner models through strictly T cell-dependent mechanisms. Critically, TP5 promoted thymic rejuvenation under immunocompromised conditions, restoring the thymus–tumor immunological balance and revitalizing peripheral T cell immunity. TP5 functionally reprogrammed T cell states, preserving effector function while ameliorating exhaustion. Furthermore, TP5 demonstrated synergistic efficacy when combined with adoptive T cell therapies, enhancing both proliferation and effector functions. Conclusions: TP5 represents a promising immunomodulator that addresses fundamental limitations of current T cell therapies by simultaneously enhancing T cell function and reversing thymic involution under immunocompromised conditions. Our findings provide compelling evidence for TP5’s clinical translation in cancer treatment.
- 13 October 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (10) , 2494
Open AccessThymopentin Enhances Antitumor Immunity Through Thymic Rejuvenation and T Cell Functional Reprogramming
Background/Objectives: T cell dysfunction represents a fundamental barrier to effective cancer immunotherapy. Although immune checkpoint blockades and adoptive cell transfer have achieved clinical success, therapeutic resistance remains prevalent across cancer types. Thymopentin (TP5), a synthetic immunomodulatory pentapeptide (Arg-Lys-Asp-Val-Tyr), has demonstrated immunostimulatory properties, yet its anticancer potential remains unexplored. The aim of this study was to investigate TP5’s antitumor efficacy and underlying immunological mechanisms. Methods: We evaluated TP5’s therapeutic effects in multiple murine tumor models, including B16-F10 melanoma, MC38 colorectal carcinoma, Hepa 1-6, and LM3 hepatocellular carcinoma. Immune cell populations and functional states were characterized using flow cytometry, ELISAs, and immunofluorescence analyses. The potential of TP5 as an adjuvant for T cell-based therapies was also systematically assessed. Results: The TP5 treatment markedly suppressed tumor growth across caner models through strictly T cell-dependent mechanisms. Critically, TP5 promoted thymic rejuvenation under immunocompromised conditions, restoring the thymus–tumor immunological balance and revitalizing peripheral T cell immunity. TP5 functionally reprogrammed T cell states, preserving effector function while ameliorating exhaustion. Furthermore, TP5 demonstrated synergistic efficacy when combined with adoptive T cell therapies, enhancing both proliferation and effector functions. Conclusions: TP5 represents a promising immunomodulator that addresses fundamental limitations of current T cell therapies by simultaneously enhancing T cell function and reversing thymic involution under immunocompromised conditions. Our findings provide compelling evidence for TP5’s clinical translation in cancer treatment.
- Open Access
- 2 March 2025
- Published by Wiley in Journal of Diabetes
- Vol. 17 (3) , e70062
Genetically Predicted Frailty Index Is Associated With Increased Risk of Multiple Metabolic Diseases: 175 226 European Participants in a Mendelian Randomization Study
Background: A relationship between frailty index (FI) and metabolic diseases (MDs) has been reported in previous observational studies. However, the causality between them remains unclear. This study aimed to examine the causal effect of FI on MDs.Methods: We performed a bidirectional two‐sample Mendelian randomization (MR) study. A recent large‐scale genome‐wide association study (GWAS) provided available data associated with FI, and summary statistics on eight MDs were collected from the IEU OpenGWAS database. Inverse variance weighted (IVW) was used as the main analysis to estimate causal effects, together with MR pleiotropy residual sum and outlier (MR‐PRESSO), MR‐Egger, Cochran's Q test, pleiotropy test, leave‐one‐out method, and MR Steiger analysis were used in the sensitivity analyses.Results: Our MR study demonstrated for the first time that elevated FI was causally associated with an increased risk of MDs including obesity (odds ratio [OR] = 1.78; 95% confidence interval [CI]: 1.17–2.70; p = 0.0075), T2DM (OR = 1.67; 95% CI: 1.24–2.24; p = 6.95 × 10−4), gout (OR = 2.45; 95% CI: 1.29–4.64; p = 0.006), hypothyroidism (OR = 1.96; 95% CI: 1.47–2.60; p = 3.47 × 10−6), and HTN (OR = 2.17; 95% CI: 1.72–2.74; p = 5.25 × 10−11). However, no causal association was found between FI and osteoporosis, vitamin D deficiency, and hyperthyroidism.Conclusions: Our findings support a causal relationship between FI and multiple MDs. This is crucial for the prevention of associated MDs in patients with frailty.
- 2 March 2025
- Published by Wiley in Journal of Diabetes
- Vol. 17 (3) , e70062
Open AccessGenetically Predicted Frailty Index Is Associated With Increased Risk of Multiple Metabolic Diseases: 175 226 European Participants in a Mendelian Randomization Study
Background: A relationship between frailty index (FI) and metabolic diseases (MDs) has been reported in previous observational studies. However, the causality between them remains unclear. This study aimed to examine the causal effect of FI on MDs.Methods: We performed a bidirectional two‐sample Mendelian randomization (MR) study. A recent large‐scale genome‐wide association study (GWAS) provided available data associated with FI, and summary statistics on eight MDs were collected from the IEU OpenGWAS database. Inverse variance weighted (IVW) was used as the main analysis to estimate causal effects, together with MR pleiotropy residual sum and outlier (MR‐PRESSO), MR‐Egger, Cochran's Q test, pleiotropy test, leave‐one‐out method, and MR Steiger analysis were used in the sensitivity analyses.Results: Our MR study demonstrated for the first time that elevated FI was causally associated with an increased risk of MDs including obesity (odds ratio [OR] = 1.78; 95% confidence interval [CI]: 1.17–2.70; p = 0.0075), T2DM (OR = 1.67; 95% CI: 1.24–2.24; p = 6.95 × 10−4), gout (OR = 2.45; 95% CI: 1.29–4.64; p = 0.006), hypothyroidism (OR = 1.96; 95% CI: 1.47–2.60; p = 3.47 × 10−6), and HTN (OR = 2.17; 95% CI: 1.72–2.74; p = 5.25 × 10−11). However, no causal association was found between FI and osteoporosis, vitamin D deficiency, and hyperthyroidism.Conclusions: Our findings support a causal relationship between FI and multiple MDs. This is crucial for the prevention of associated MDs in patients with frailty.
- 5 February 2025
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 76 (3) , 315-325
Association between Healthy Eating Index 2015 and metabolic syndrome among US cancer survivors: evidence from NHANES 2005–2016
Our study examined the relationship between diet quality and the prevalence of metabolic syndrome (MetS) among 1779 U.S. cancer survivors using data from the National Health and Nutrition Examination Survey (NHANES, 2005-2016). Diet quality was assessed using the Healthy Eating Index 2015 (HEI-2015). Higher HEI-2015 scores were linked to significantly lower MetS prevalence (OR: 0.51, 95% CI: 0.32-0.80). Specifically, a higher intake of seafood and plant proteins, and fatty acids, coupled with a reduced intake of added sugars, was associated with decreased odds of MetS prevalence (OR: 0.93; 95% CI, 0.86-0.99) in cancer survivors. Additionally, a better diet quality was linked to lower prevalence of high waist circumference, elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol and high fasting glucose levels (OR, 0.44; 95% CI, 0.27-0.72). These results suggest that adopting healthy dietary habits may prevent MetS in cancer survivors.
- 5 February 2025
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 76 (3) , 315-325
Association between Healthy Eating Index 2015 and metabolic syndrome among US cancer survivors: evidence from NHANES 2005–2016
Our study examined the relationship between diet quality and the prevalence of metabolic syndrome (MetS) among 1779 U.S. cancer survivors using data from the National Health and Nutrition Examination Survey (NHANES, 2005-2016). Diet quality was assessed using the Healthy Eating Index 2015 (HEI-2015). Higher HEI-2015 scores were linked to significantly lower MetS prevalence (OR: 0.51, 95% CI: 0.32-0.80). Specifically, a higher intake of seafood and plant proteins, and fatty acids, coupled with a reduced intake of added sugars, was associated with decreased odds of MetS prevalence (OR: 0.93; 95% CI, 0.86-0.99) in cancer survivors. Additionally, a better diet quality was linked to lower prevalence of high waist circumference, elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol and high fasting glucose levels (OR, 0.44; 95% CI, 0.27-0.72). These results suggest that adopting healthy dietary habits may prevent MetS in cancer survivors.
- Open Access
- 16 September 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1430334
Prenatal glucocorticoids exposure and adverse cardiovascular effects in offspring
Glucocorticoids (GCs) are steroid hormones fundamental to the body’s normal physiological functions and are pivotal in fetal growth and development. During gestation, the mother’s cortisol concentration (active GCs) escalates to accommodate the requirements of fetal organ development and maturation. A natural placental GCs barrier, primarily facilitated by 11β hydroxysteroid dehydrogenase 2, exists between the mother and fetus. This enzyme transforms biologically active cortisol into biologically inactive corticosterone, thereby mitigating fetal GCs exposure. However, during pregnancy, the mother may be vulnerable to adverse factor exposures such as stress, hypoxia, caffeine, and synthetic GCs use. In these instances, maternal serum GCs levels may surge beyond the protective capacity of the placental GCs barrier. Moreover, these adverse factors could directly compromise the placental GCs barrier, resulting in excessive fetal exposure to GCs. It is well-documented that prenatal GCs exposure can detrimentally impact the offspring’s cardiovascular system, particularly in relation to blood pressure, vascular function, and heart function. In this review, we succinctly delineate the alterations in GCs levels during pregnancy and the potential mechanisms driving these changes, and also analyze the possible causes of prenatal GCs exposure. Furthermore, we summarize the current advancements in understanding the adverse effects and mechanisms of prenatal GCs exposure on the offspring’s cardiovascular system.
- 16 September 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1430334
Open AccessPrenatal glucocorticoids exposure and adverse cardiovascular effects in offspring
Glucocorticoids (GCs) are steroid hormones fundamental to the body’s normal physiological functions and are pivotal in fetal growth and development. During gestation, the mother’s cortisol concentration (active GCs) escalates to accommodate the requirements of fetal organ development and maturation. A natural placental GCs barrier, primarily facilitated by 11β hydroxysteroid dehydrogenase 2, exists between the mother and fetus. This enzyme transforms biologically active cortisol into biologically inactive corticosterone, thereby mitigating fetal GCs exposure. However, during pregnancy, the mother may be vulnerable to adverse factor exposures such as stress, hypoxia, caffeine, and synthetic GCs use. In these instances, maternal serum GCs levels may surge beyond the protective capacity of the placental GCs barrier. Moreover, these adverse factors could directly compromise the placental GCs barrier, resulting in excessive fetal exposure to GCs. It is well-documented that prenatal GCs exposure can detrimentally impact the offspring’s cardiovascular system, particularly in relation to blood pressure, vascular function, and heart function. In this review, we succinctly delineate the alterations in GCs levels during pregnancy and the potential mechanisms driving these changes, and also analyze the possible causes of prenatal GCs exposure. Furthermore, we summarize the current advancements in understanding the adverse effects and mechanisms of prenatal GCs exposure on the offspring’s cardiovascular system.